SignatureFD’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.38K Buy
+981
New +$2.4K ﹤0.01% 3099
2026
Q1
Sell
-182
Closed -$943 3561
2025
Q4
$943 Hold
182
﹤0.01% 3129
2025
Q3
$768 Hold
182
﹤0.01% 3129
2025
Q2
$666 Sell
182
-235
-56% -$876 ﹤0.01% 3070
2025
Q1
$1.8K Buy
417
+235
+129% +$949 ﹤0.01% 2902
2024
Q4
$582 Hold
182
﹤0.01% 3123
2024
Q3
$521 Sell
182
-19
-9% -$53 ﹤0.01% 3094
2024
Q2
$563 Buy
+201
New +$539 ﹤0.01% 2974
2024
Q1
Sell
-700
Closed -$2.86K 3237
2023
Q4
$2.86K Buy
+700
New +$1.96K ﹤0.01% 2669
2023
Q3
Sell
-713
Closed -$2.37K 3272
2023
Q2
$2.37K Sell
713
-647
-48% -$1.91K ﹤0.01% 2755
2023
Q1
$2.9K Buy
1,360
+151
+12% +$373 ﹤0.01% 2698
2022
Q4
$3.25K Buy
1,209
+536
+80% +$1.56K ﹤0.01% 2636
2022
Q3
$2K Buy
+673
New +$3.04K ﹤0.01% 2821
2021
Q4
Sell
-200
Closed -$3K 3220
2021
Q3
$3K Buy
+200
New +$3.11K ﹤0.01% 2539
2020
Q2
Sell
-150
Closed 2616
2020
Q1
$0 Buy
+150
New +$642 ﹤0.01% 2408

Other funds holding ORGO

SignatureFD's ORGO Position: Q2 2026 in Review

SignatureFD opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 981 shares worth $2.38K. The stake represents ﹤0.01% of the portfolio and ranks #3099 among its holdings. This is a return to the name: SignatureFD previously reported a position in ORGO as recently as Q4 2025.

SignatureFD first reported a position in ORGO in Q1 2020 and has held it in 15 quarters since. The position peaked at $3.25K in Q4 2022. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • SignatureFD held 981 shares of Organogenesis Holdings worth $2.38K as of Q2 2026.
  • Organogenesis Holdings was a new SignatureFD position in Q2 2026.
  • Organogenesis Holdings made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3099 holding.
  • SignatureFD first reported a position in Organogenesis Holdings in Q1 2020 and has held it in 15 quarters since.
  • SignatureFD's Organogenesis Holdings position peaked at $3.25K in Q4 2022.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.